Pharsight

Impax patents expiration

1. Adrenaclick patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7297136 IMPAX Medicine injection devices and methods
Jan, 2025

(1 year, 3 months from now)

US10166334 IMPAX Medicine injection apparatuses
Jan, 2025

(1 year, 3 months from now)

US7621891 IMPAX Method and apparatus for delivering epinephrine
Feb, 2025

(1 year, 4 months from now)

US7905352 IMPAX Kits containing medicine injection devices and containers
Apr, 2027

(3 years from now)

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 30 May, 2003

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

ADRENACLICK family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic